This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1982 Oct;10(5):465-94.

doi: 10.1007/BF01059032.

Clinical pharmacokinetics of disopyramide

A Karim, C Nissen, D L Azarnoff

PMID: 6762414
DOI: 10.1007/BF01059032

Review

Clinical pharmacokinetics of disopyramide

A Karim et al. J Pharmacokinet Biopharm. 1982 Oct.

. 1982 Oct;10(5):465-94.

doi: 10.1007/BF01059032.

Authors

A Karim, C Nissen, D L Azarnoff

PMID: 6762414
DOI: 10.1007/BF01059032

No abstract available

PubMed Disclaimer

Similar articles

Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
Rangno RE, Warnica W, Ogilvie RI, Kreeft J, Bridger E. Rangno RE, et al. J Int Med Res. 1976;4(1 Suppl):54-8. J Int Med Res. 1976. PMID: 1026530 No abstract available.
[Clinical pharmacology of disopyramide].
Rewerski W, Dorociak A, Walczak F, Dobiasz A. Rewerski W, et al. Pol Tyg Lek. 1980 Jul 21;35(29):1109-12. Pol Tyg Lek. 1980. PMID: 7001399 Review. Polish. No abstract available.
Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A, Kook C, Novotney RL, Zagarella J, Campion J. Karim A, et al. Drug Metab Dispos. 1978 May-Jun;6(3):338-45. Drug Metab Dispos. 1978. PMID: 26556
Disopyramide pharmacokinetics and bioavailability.
Dubetz DK, Brown NN, Hooper WD, Eadie MJ, Tyrer JH. Dubetz DK, et al. Br J Clin Pharmacol. 1978 Sep;6(3):279-81. doi: 10.1111/j.1365-2125.1978.tb04598.x. Br J Clin Pharmacol. 1978. PMID: 687507 Free PMC article. Clinical Trial. No abstract available.
[Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
Witkowska M. Witkowska M. Kardiol Pol. 1981;24(7):505-17. Kardiol Pol. 1981. PMID: 7024612 Review. Polish. No abstract available.

See all similar articles

Cited by

Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment?
Braun J, Sörgel F, Gluth WP, Oie S. Braun J, et al. Eur J Clin Pharmacol. 1988;35(3):313-7. doi: 10.1007/BF00558271. Eur J Clin Pharmacol. 1988. PMID: 3181285
Free drug concentration monitoring in clinical practice. Rationale and current status.
Svensson CK, Woodruff MN, Baxter JG, Lalka D. Svensson CK, et al. Clin Pharmacokinet. 1986 Nov-Dec;11(6):450-69. doi: 10.2165/00003088-198611060-00003. Clin Pharmacokinet. 1986. PMID: 3542337 Review.
Therapeutic drug monitoring: antiarrhythmic drugs.
Campbell TJ, Williams KM. Campbell TJ, et al. Br J Clin Pharmacol. 1998 Oct;46(4):307-19. doi: 10.1046/j.1365-2125.1998.t01-1-00768.x. Br J Clin Pharmacol. 1998. PMID: 9803978 Free PMC article. Review.
A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers.
Longmore J, Berry JL, Szabadi E, Bradshaw CM. Longmore J, et al. Eur J Clin Pharmacol. 1990;39(3):305-9. doi: 10.1007/BF00315118. Eur J Clin Pharmacol. 1990. PMID: 2257872 Clinical Trial.
Atenolol inhibits the elimination of disopyramide.
Bonde J, Bødtker S, Angelo HR, Svendsen TL, Kampmann JP. Bonde J, et al. Eur J Clin Pharmacol. 1985;28(1):41-3. doi: 10.1007/BF00635706. Eur J Clin Pharmacol. 1985. PMID: 3987784

See all "Cited by" articles

References

1. J Chromatogr. 1975 Jun 18;109(2):432-5 - PubMed
1. Drug Metab Dispos. 1978 May-Jun;6(3):346-8 - PubMed
1. Aust N Z J Med. 1980 Aug;10(4):426-9 - PubMed
1. J Int Med Res. 1976;4(1 Suppl):54-8 - PubMed
1. Anal Chem. 1979 Mar;51(3):455-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions